Assessing Treatment Benefit in Immuno-Oncology
September 25, 2018
Free Live Webinar: Assessing Treatment Benefit in Immuno-Oncology
In this webinar we reviewed key issues related to endpoints in immuno-oncology, with a brief overview of the four different sets of criteria for response assessment in immunotherapy. Then we reviewed the novel approaches both for the design and analysis of clinical trials, including the assessment of the net benefit through the use of generalized pairwise comparison (GPC).
CLICK HERE TO VIEW THE RECORDED WEBINAR |
KEY LEARNING OBJECTIVES:
In this webinar, featured speakers :
- Reviewed key issues in the recent literature related to endpoints in immuno-oncology, with a brief overview of the four different sets of criteria that have been proposed for response assessment in immunotherapy.
- Used examples from the recent literature to illustrate the limitations of current statistical methods in the assessment of progression-free survival and overall survival,
- Reviewed the novel approaches that have been proposed both for the design and analysis of clinical trials, including the assessment of the net benefit through the use of generalized pairwise comparison (GPC)
Questions and answers during the webinar: QA – Webinar Benefit from Immunotherapy